A team of scientists, including researchers from University College London (UCL), has discovered key differences in how four ...

Scientists have found a promising new way to deliver targeted treatments to diseased parts of the brain, and it could be a ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

Biogen BIIB will report first-quarter 2025 results on May 1, before market open. In the last reported quarter, the company's ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

About 15% of the world’s population — more than 1-billion people — are affected by neurological disorders, from commonly known diseases like Alzheimer’s and Parkinson’s to hundreds of lesser-known, ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Digital technology is a critical to addressing the ever-expanding burden of dementia, write Prof Dag Aarsland and Dr Antonio ...

Harvard University has filed a lawsuit against the United States Department of Health and Human Services (HHS) and other ...